The aim of our lab is to support basic, translational and clinical research pertinent to the 4R medicine (ie. Replace, Repair, Regenerate and Reprogram) related to skeleton diseases and aging. The skeleton diseases originates from developmental abnormalities, growth impairment, repair dysfunction, aging or acquired pathologies. Among these diseases, we are particularly interested in discovering new therapeutic strategies for osteoporosis, osteoarthritis, discarthrosis and periodontitis. Due to the increasing clinical situations where skeletal tissues are lost or compromised (bone, cartilage, teeth, disc..) we also focuse our research efforts on the use of stem cells, calcium phosphate ceramics and hydrogels for the development of reconstructive therapeutics. By formalizing an interdisciplinary approach, and providing researchers with a functional organizational structure, RMeS aims at offering a strong support and stimulating environment for exploring the limit of knowledge in 4R medicine.
Company Details
- Employees
- 35
- Founded
- -
- Address
- Place Alexis Ricordeau, Nantes,pays De La Loire 44000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://rmes.univ-nantes.fr/
- HQ
- Nantes, Pays de la Loire
Regenerative Medicine And Skeleton, Inserm U1229 Rmes Questions
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's website is https://rmes.univ-nantes.fr/
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's LinkedIn profile is https://fr.linkedin.com/company/inserm-u1229-rmes
Regenerative Medicine And Skeleton, Inserm U1229 Rmes has
35 employees.
View email and phone details for 35
employees at Regenerative Medicine And Skeleton, Inserm U1229 Rmes.
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's industry is
Biotechnology Research
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's top competitors are
Inserm Grand Ouest,
Crci2na,
Biomat France,
Go-Ev,
Tissue Engineering And Regenerative Medicine International Society, Inc. (Termis),
Sfbtm,
L'institut Du Thorax,
Master Sciences Du Médicament Et Des Produits De Santé - Nantes Université,
Biotis Bordeaux,
Inserm.
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's categories are Biotechnology Research
Regenerative Medicine And Skeleton, Inserm U1229 Rmes's founding year is 2022
